Skip to main content
Study
Classic

Adverse drug events in ambulatory care.

Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. New Engl J Med. 2003;348(16)(16):1556-1564.

Save

Print

March 6, 2005
Gandhi TK, Weingart SN, Borus J, et al. New Engl J Med. 2003;348(16):1556-1564.

This prospective cohort study evaluated more than 1200 outpatient prescriptions, surveyed patients, and conducted a chart review during a 4-week period. Investigators discovered that 25% of patients experienced an adverse drug event with selective serotonin-reuptake inhibitors, beta blockers, angiotensin-converting-enzyme inhibitors, and nonsteroidal anti-inflammatory medication classes the most frequently implicated. The rate of ADEs in this study approached 27 per 100 patients, a rate that quadruples those estimated in the inpatient setting. The authors suggest a number of preventive strategies that may reduce the nearly one third of events that were deemed preventable.

Save

Print

Cite
Citation

Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. New Engl J Med. 2003;348(16)(16):1556-1564.